This inventor holds 1 USPTO granted patent and 6 published patent applications and 1 EPO patent. Top assignee: Cedars-Sinai Medical Center. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Talin Haritunians: Innovator in Medical Prognosis
Introduction
Talin Haritunians is a notable inventor based in Encino, California. She has made significant contributions to the field of medicine, particularly in the area of ulcerative colitis. Her innovative work focuses on predicting the development of medically refractory ulcerative colitis (MR-UC), which can lead to severe health complications.
Latest Patents
Talin holds a patent for "Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy." This patent discloses methods for predicting the development of MR-UC in patients. One embodiment of her invention involves prognosing ulcerative colitis by determining the presence or absence of specific risk variants. The presence of these risk variants indicates a severe and/or aggressive form of ulcerative colitis, which is crucial for timely medical intervention.
Career Highlights
Talin Haritunians is affiliated with Cedars-Sinai Medical Center, where she applies her expertise in medical research. Her work has the potential to significantly impact patient outcomes by enabling earlier and more accurate diagnoses of ulcerative colitis.
Collaborations
Some of her notable coworkers include Jerome I. Rotter and Kent D. Taylor, who contribute to the collaborative efforts in advancing medical research and innovation.
Conclusion
Talin Haritunians exemplifies the spirit of innovation in the medical field through her groundbreaking patent and research efforts. Her work not only enhances the understanding of ulcerative colitis but also paves the way for improved patient care.